- About Us
- Services & Solutions
- Technologies
- Discovery
- Reagent Materials Generation
- Monoclonal Antibody Discovery
- Bispecific & Multispecific Antibody Generation
- Lead Optimization
- In Vitro Lead Characterization
- In Vivo Lead Characterization
- Other Molecular Modalities
- IND Filing Support
- Protein Sciences
- Protein Production
- Protein Analytics
- Bioinformatics
- Protein Sciences
- Mammalian
- Microbial
- mRNA
- Viral Vaccines
- WuXi XDC – Bioconjugation
- Testing
- Careers
- Investors
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- CareersAbout Us
- InvestorsAbout Us
- News & ResourcesAbout Us
Perspectives
Dr. Weichang Zhou, CTO of WuXi Biologics: Secure the Future of Bioprocessing
Sep. 09, 2022
Dr. Weichang Zhou, CTO of WuXi Biologics: Secure the Future of Bioprocessing
Dr. Weichang Zhou, CTO and executive vice president of WuXi Biologics, recently had an article published on industry media website GEN News. He stressed the importance of adopting continuous bioprocessing, single-use systems, and digitalization technologies. Please click the link to read the full article.
Notice:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?